We are looking forward to your inquiry!


    Your competent partner in the Life Science sector!

About us

SANEMUS AG focuses on investing in company and asset shares in the German healthcare market and offers strategic, financial and merger&acquisition advisory in this context. It was founded in 2006 by experienced healthcare professionals in Munich. The investment focus is exclusively put on the Life Science sector with its submarkets pharmaceutical industry, biotechnology, medical technology, diagnostics and E-health.

Our Mission

We assist to develop commercially attractive companies from promising Start-Ups from the Life Science sector due to the complementary strategic and financial advisory services offered.

We provide strategic input to substantially increase the value of Life Science companies by sophisticated lifecycle und portfolio management as well as strategic partnering.

We advise investors in Life Science investments – either in single investment projects or in Venture Capital or Private Equity Funds – to achieve an individually optimal value increase of their investments.

Current news

The Life Science Industry in 2017

In the cover story of the latest issue of Life Sciences Platform, "Biotechnology 2017", Dr. Thiel gives an overview of the development of the life science industry in the current year. Many doubts were raised trough electioneering in the…

Supporting a diagnostics start-up in finding new investors

SANEMUS is supporting a diagnostics start-up focused on the identification and characterization of circulating tumor cells (CTC) in finding new investors. The start-up has developed a patent-protected innovative diagnostic system, which is able…

Supporting a biotech start-up in attracting venture capital

The SANEMUS team supervises a biotech start-up in attracting venture capital, which has developed a proprietary technology platform for the encapsulation of nucleid acids (siRNA, mRNA) as well as low molecular compounds. The goal is the development…

German family office invests in European Life Science VC fund

A German family office in the field of plant manufacturing has again invested tens of millions in an European Life Science VC fund on the recommendation of SANEMUS AG. At that time, SANEMUS prepared an overview of the healthcare market with…
BVK- Bundesverand Deutscher Kapitalbeteiligungsgesellschaften
Going Public - Das Kapitalmarkt-Portal
Forum MedTech Pharma